OPK

OPKO Health, Inc. OPK

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode OPK PSNL FLGT DMTKQ INO VXRT CODX IBIO
6M 6.34 % 147.56 % 18.47 % 9 900.00 % 59.63 % -5.19 % 2.71 % -34.06 %
YTD 4.14 % 29.51 % 22.20 % 0.00 % 41.21 % -53.01 % -47.55 % -67.30 %
1Y 2.72 % 77.68 % 10.61 % -99.73 % -54.91 % -56.37 % -71.29 % -69.57 %
3Y -15.17 % 215.95 % -40.02 % -100.00 % -87.40 % -81.55 % -89.01 % -98.32 %
5Y -64.26 % -71.43 % -46.30 % -100.00 % -98.33 % -95.60 % -97.41 % -99.93 %
10Y -82.26 % -71.50 % 145.21 % -100.00 % -96.21 % -98.53 % -93.48 % -99.98 %
From the beginning -66.44 % -71.50 % 145.21 % -100.00 % -99.64 % -99.71 % -93.48 % -99.98 %

Dividend

Inovio Pharmaceuticals, Inc.

Vaxart, Inc.